Page last updated: 2024-12-08

penilloate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

penilloic acid: formed from decarboxylation of penicilloic acid; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID255293
MeSH IDM0068528

Synonyms (21)

Synonym
5,5-dimethyl-2-{[(2-phenylacetyl)amino]methyl}-1,3-thiazolane-4-carboxylic acid
IDI1_015783
nsc-80686
nsc80686
MAYBRIDGE3_004396
penilloic acid
HMS1443H18
501-34-8
5,5-dimethyl-2-[[(2-phenylacetyl)amino]methyl]-1,3-thiazolidine-4-carboxylic acid
penilloate
penillosaure
LRWFMQCGNBOTQP-UHFFFAOYSA-N
STL454271
5,5-dimethyl-2-{[(phenylacetyl)amino]methyl}-1,3-thiazolidine-4-carboxylic acid
28325-47-5
DTXSID60292186
2-{[(1-hydroxy-2-phenylethylidene)amino]methyl}-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid
DTXSID00964517
Q27277833
5,5-dimethyl-2-((2-phenylacetamido)methyl)thiazolidine-4-carboxylic acid
(2r-trans)-5,5-dimethyl-2-[[(phenylacetyl)amino]methyl]-4-thiazolidinecarboxylicacid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (42.11)18.7374
1990's2 (10.53)18.2507
2000's0 (0.00)29.6817
2010's6 (31.58)24.3611
2020's3 (15.79)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (5.26%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other18 (94.74%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]